Irum Fatima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irum Fatima has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Farah Naz Qamar
The Aga Khan University
2 shared publications Alice S. Carter
Washington District of Columbia Sabin Vaccine Institute
1 shared publication- Alice S. Carter
Vaccine Epidemiology, Global Immunization, Sabin Vaccine Institute, Washington, DC 20006, USA
1 shared publication - Andrew J. Pollard
Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK
1 shared publication Aneeta Hotwani
Department of Pediatrics and Child Health, Aga Khan University Hospital, Karachi, Pakistan
1 shared publication- Bakary Conteh
Medical Research Council Unit The Gambia at the London School of Hygiene and Tropical Medicine, Banjul, The Gambia
1 shared publication
Latest Publications
- Open Access
- 12 May 2026
- Published by Elsevier in Physics Letters B
- Vol. 878
Conformal symmetries driven exact higher-dimensional Kaluza-Klein cosmological solutions and in non-conservative gravitational framework
- 12 May 2026
- Published by Elsevier in Physics Letters B
- Vol. 878
Open AccessConformal symmetries driven exact higher-dimensional Kaluza-Klein cosmological solutions and in non-conservative gravitational framework
- Open Access
Prevalence and Risk Factors of Respiratory Tract Infections Following Medically-Attended-Diarrhea in Children Aged 6-35 Months: Enterics for Global Health (EFGH)- Shigella Surveillance Study, 2022-2024
Globally, respiratory tract infections (RTI) are the main cause of morbidity, and in Low-middle-income countries (LMICs) RTI including pneumonia are a leading cause of morbidity and mortality in children <5 years. Diarrheal illness increases RTI risk in young children through micronutrient depletion, and immune stress, yet data on post-diarrhea RTI burden in LMICs are limited. We determined the prevalence and risk factors of RTI within three months following medically-attended diarrhea (MAD) in children aged 6-35 months enrolled in seven EFGH country sites in Asia, Africa and South America. The EFGH study prospectively enrolled children aged 6-35 months with MAD in selected health facilities during a 24-month period from 2022 to 2024 and followed them for three months. RTI was defined as cough or difficulty breathing and the presence of one of the following symptoms at any scheduled or unscheduled visit during follow-up: stridor; fast-breathing; oxygen saturation <90%; or chest indrawing. The period prevalence and 95% confidence intervals of RTI were calculated, and correlates of RTI were assessed using modified-Poisson regression. From June 2022 to August 2024, 9,476 children aged 6-35 months presenting with MAD in the EFGH study sites were screened: 9,116 (96.2%) included in the current study. Nearly half were female (46.7%), and median age was 15 months. Overall, 48.5% received all age-appropriate vaccines, and 87.6% received the pneumococcal vaccine, with significant variation across countries. Nearly one-quarter of children were stunted, 17.2% wasted, and 21.9% underweight. RTI occurred in 3.8% of children during the three-month follow-up, mostly within the first month. Higher prevalence of RTI occurred among children aged 12-23 months (8.7%), those undernourished (16.1%), unvaccinated (4.0%) or living in poor sanitation settings (4.1%). While children who received all age-appropriate or pneumococcal vaccinations had a lower crude prevalence of RTI, these associations were not statistically significant after adjusting for age, sex and study site. RTI was infrequently observed in the three months following MAD presentation, with significant variability by site and with the highest prevalence in Malawi. RTI risk was highest in 12-23-month-olds and among children with undernutrition, and those living in poor sanitation conditions.
Open AccessPrevalence and Risk Factors of Respiratory Tract Infections Following Medically-Attended-Diarrhea in Children Aged 6-35 Months: Enterics for Global Health (EFGH)- Shigella Surveillance Study, 2022-2024
Globally, respiratory tract infections (RTI) are the main cause of morbidity, and in Low-middle-income countries (LMICs) RTI including pneumonia are a leading cause of morbidity and mortality in children <5 years. Diarrheal illness increases RTI risk in young children through micronutrient depletion, and immune stress, yet data on post-diarrhea RTI burden in LMICs are limited. We determined the prevalence and risk factors of RTI within three months following medically-attended diarrhea (MAD) in children aged 6-35 months enrolled in seven EFGH country sites in Asia, Africa and South America. The EFGH study prospectively enrolled children aged 6-35 months with MAD in selected health facilities during a 24-month period from 2022 to 2024 and followed them for three months. RTI was defined as cough or difficulty breathing and the presence of one of the following symptoms at any scheduled or unscheduled visit during follow-up: stridor; fast-breathing; oxygen saturation <90%; or chest indrawing. The period prevalence and 95% confidence intervals of RTI were calculated, and correlates of RTI were assessed using modified-Poisson regression. From June 2022 to August 2024, 9,476 children aged 6-35 months presenting with MAD in the EFGH study sites were screened: 9,116 (96.2%) included in the current study. Nearly half were female (46.7%), and median age was 15 months. Overall, 48.5% received all age-appropriate vaccines, and 87.6% received the pneumococcal vaccine, with significant variation across countries. Nearly one-quarter of children were stunted, 17.2% wasted, and 21.9% underweight. RTI occurred in 3.8% of children during the three-month follow-up, mostly within the first month. Higher prevalence of RTI occurred among children aged 12-23 months (8.7%), those undernourished (16.1%), unvaccinated (4.0%) or living in poor sanitation settings (4.1%). While children who received all age-appropriate or pneumococcal vaccinations had a lower crude prevalence of RTI, these associations were not statistically significant after adjusting for age, sex and study site. RTI was infrequently observed in the three months following MAD presentation, with significant variability by site and with the highest prevalence in Malawi. RTI risk was highest in 12-23-month-olds and among children with undernutrition, and those living in poor sanitation conditions.
- Open Access
- 20 July 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 147, 107187
Longevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan
- 20 July 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 147, 107187
Open AccessLongevity of immune response after a single dose of typhoid conjugate vaccine against Salmonella Typhi among children in Hyderabad, Pakistan